[go: up one dir, main page]

MX2021012349A - Dispositivos y metodos de unidades multiples para administracion de farmacos. - Google Patents

Dispositivos y metodos de unidades multiples para administracion de farmacos.

Info

Publication number
MX2021012349A
MX2021012349A MX2021012349A MX2021012349A MX2021012349A MX 2021012349 A MX2021012349 A MX 2021012349A MX 2021012349 A MX2021012349 A MX 2021012349A MX 2021012349 A MX2021012349 A MX 2021012349A MX 2021012349 A MX2021012349 A MX 2021012349A
Authority
MX
Mexico
Prior art keywords
drug
delivery devices
drug delivery
unit
methods
Prior art date
Application number
MX2021012349A
Other languages
English (en)
Inventor
Heejin Lee
Karen Daniel
Matthew Sansone
Original Assignee
Taris Biomedical Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taris Biomedical Llc filed Critical Taris Biomedical Llc
Publication of MX2021012349A publication Critical patent/MX2021012349A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/048—Macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/08—Materials for coatings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
    • A61M31/007—Injectors for solid bodies, e.g. suppositories
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0092—Hollow drug-filled fibres, tubes of the core-shell type, coated fibres, coated rods, microtubules or nanotubes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/10—Trunk
    • A61M2210/1078—Urinary tract
    • A61M2210/1085—Bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Surgery (AREA)
  • Vascular Medicine (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Anesthesiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Media Introduction/Drainage Providing Device (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Los dispositivos de administración de fármacos implantables incluyen una carcasa que define un depósito, una primera unidad dentro del depósito, y una segunda unidad dentro del depósito. La primera unidad contiene un fármaco y la segunda unidad contiene un agente funcional que facilita la liberación del fármaco. Los dispositivos de administración de fármacos intravesicales incluyen una porción de carcasa que contiene una formulación de fármaco y una porción de carcasa que contiene un excipiente, y están configurados para liberar el fármaco de acuerdo con un primer perfil de liberación y el excipiente de acuerdo con un segundo perfil de liberación. Los métodos incluyen la inserción de cualquiera de estos dispositivos en un paciente y la liberación de fármaco desde el dispositivo.
MX2021012349A 2013-08-19 2016-02-05 Dispositivos y metodos de unidades multiples para administracion de farmacos. MX2021012349A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361867245P 2013-08-19 2013-08-19
US201361877610P 2013-09-13 2013-09-13

Publications (1)

Publication Number Publication Date
MX2021012349A true MX2021012349A (es) 2021-10-22

Family

ID=51422208

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2016001621A MX386955B (es) 2013-08-19 2014-08-19 Dispositivos y métodos de unidades múltiples para administración de fármacos.
MX2021012349A MX2021012349A (es) 2013-08-19 2016-02-05 Dispositivos y metodos de unidades multiples para administracion de farmacos.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
MX2016001621A MX386955B (es) 2013-08-19 2014-08-19 Dispositivos y métodos de unidades múltiples para administración de fármacos.

Country Status (25)

Country Link
US (4) US10729823B2 (es)
EP (3) EP4234036A3 (es)
JP (5) JP6486359B2 (es)
KR (3) KR102503010B1 (es)
CN (3) CN113413537A (es)
AU (4) AU2014309012B2 (es)
BR (1) BR112016002646B1 (es)
CA (2) CA3173027A1 (es)
CY (1) CY1123474T1 (es)
DK (1) DK3035991T3 (es)
ES (2) ES2817838T3 (es)
HR (1) HRP20201421T1 (es)
HU (1) HUE051336T2 (es)
IL (3) IL299897B2 (es)
LT (1) LT3035991T (es)
MX (2) MX386955B (es)
PL (1) PL3035991T3 (es)
PT (1) PT3035991T (es)
RS (1) RS60847B1 (es)
RU (1) RU2687596C2 (es)
SG (2) SG10202004675QA (es)
SI (1) SI3035991T1 (es)
SM (1) SMT202000472T1 (es)
WO (1) WO2015026813A1 (es)
ZA (2) ZA201600788B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX365688B (es) 2012-08-31 2019-06-11 Taris Biomedical Llc Sistemas de administracion de farmaco y metodos para el tratamiento del cancer de vejiga que comprenden oxaliplatino.
CN104812395A (zh) 2012-08-31 2015-07-29 塔里斯生物医药公司 用于治疗前列腺的药物递送系统和方法
JP2016508842A (ja) 2013-03-05 2016-03-24 タリス バイオメディカル エルエルシー 装置の開口部を通じて制御された薬物放出のための薬物送達装置及び方法
AU2014227914B2 (en) 2013-03-15 2018-05-10 Taris Biomedical Llc Drug delivery devices and methods for drug delivery
JP6901858B2 (ja) * 2014-03-06 2021-07-14 タリス バイオメディカル エルエルシー 薬物送達システム及びゲムシタビンによる膀胱がんの治療方法
ES2849562T3 (es) 2014-05-12 2021-08-19 Taris Biomedical Llc Dispositivos de administración de fármacos
EP3160442B1 (en) 2014-06-26 2019-03-06 TARIS Biomedical LLC Intravesical drug delivery devices and methods including elastic polymer-drug matrix systems
ES2734394T3 (es) * 2015-03-30 2019-12-05 Taris Biomedical Llc Dispositivos para la administración local fármacos al tracto urinario superior
JP7425534B2 (ja) 2015-04-23 2024-01-31 タリス バイオメディカル エルエルシー 薬物透過性構成要素を有する薬物送達デバイス及び方法
US20180117219A1 (en) * 2015-04-29 2018-05-03 Northwestern University 3d printing of biomedical implants
CN105056376A (zh) * 2015-08-21 2015-11-18 崔尚品 一种治疗宫颈炎和宫颈hpv感染的医疗器械
WO2017151983A1 (en) * 2016-03-02 2017-09-08 Taris Biomedical Llc Osmotic drug delivery devices and methods of making osmotic drug delivery devices
HUE060965T2 (hu) 2016-05-06 2023-04-28 Taris Biomedical Llc Eljárás az alsó húgyúti urotél rák kezelésére
MX2019009080A (es) * 2017-02-01 2019-10-15 Taris Biomedical Llc Dispositivos de suministro de farmacos in vivo y metodos para el suministro de farmacos.
CA3071014A1 (en) 2017-07-25 2019-01-31 Taris Biomedical Llc Methods of treating tumor metastasis
US10792297B2 (en) 2017-11-08 2020-10-06 Taris Biomedical Llc Methods of treatment and maintenance therapy for bladder cancer using gemcitabine
CA3107461A1 (en) 2018-08-01 2020-02-06 Taris Biomedical Llc Methods of treating overactive bladder using trospium
MA54171A (fr) * 2018-11-09 2021-09-15 Taris Biomedical Llc Dispositifs et systèmes d'administration de médicament pour l'administration locale de médicament au tractus urinaire supérieur
US12433597B2 (en) 2019-06-04 2025-10-07 Trisalus Life Sciences, Inc. Atraumatic occlusive system with compartment for measurement of vascular pressure change
KR20240118888A (ko) 2021-12-21 2024-08-05 타리스 바이오메디컬 엘엘씨 방광내 장치용 비뇨기 배치 카테터
WO2024092159A1 (en) 2022-10-28 2024-05-02 Taris Biomedical Llc Methods of treating bladder cancer with gemcitabine
KR20250168664A (ko) 2023-04-10 2025-12-02 타리스 바이오메디컬 엘엘씨 바실루스 칼메트-구에린 요법에 무반응성인 고위험 근육 비침습성 방광암을 치료하는 방법에 사용하기 위한 젬시타빈
TW202532086A (zh) 2023-10-02 2025-08-16 美商塔里斯生物醫學有限責任公司 治療對卡介苗療法無反應之高風險非肌肉侵襲性膀胱癌之方法

Family Cites Families (185)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3089815A (en) 1951-10-11 1963-05-14 Lieb Hans Injectable pharmaceutical preparation, and a method of making same
US3854480A (en) 1969-04-01 1974-12-17 Alza Corp Drug-delivery system
US3625214A (en) 1970-05-18 1971-12-07 Alza Corp Drug-delivery device
US3675647A (en) 1970-08-05 1972-07-11 Alza Corp Intrauterine contraceptive device
US3675648A (en) 1970-08-05 1972-07-11 Alza Corp Intrauterine contraceptive device
US3710795A (en) 1970-09-29 1973-01-16 Alza Corp Drug-delivery device with stretched, rate-controlling membrane
US3948254A (en) * 1971-11-08 1976-04-06 Alza Corporation Novel drug delivery device
US4016251A (en) 1972-08-17 1977-04-05 Alza Corporation Vaginal drug dispensing device
US3888975A (en) 1972-12-27 1975-06-10 Alza Corp Erodible intrauterine device
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US3901232A (en) 1973-10-26 1975-08-26 Alza Corp Integrated device for administering beneficial drug at programmed rate
US3935860A (en) 1974-08-21 1976-02-03 Alza Corporation Intrauterine device with restrictor for maintaining device in uterine cavity
US4111203A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system with means for improving delivery kinetics of system
US4111202A (en) * 1976-11-22 1978-09-05 Alza Corporation Osmotic system for the controlled and delivery of agent over time
US4210139A (en) 1979-01-17 1980-07-01 Alza Corporation Osmotic device with compartment for governing concentration of agent dispensed from device
US4235236A (en) 1979-02-12 1980-11-25 Alza Corporation Device for dispensing drug by combined diffusional and osmotic operations
US4392848A (en) 1979-06-25 1983-07-12 The Procter & Gamble Company Catheterization
US4309996A (en) 1980-04-28 1982-01-12 Alza Corporation System with microporous releasing diffusor
US4326522A (en) 1980-06-09 1982-04-27 Pitman-Moore, Inc. Mesh-covered bolus
GB2079158B (en) 1980-06-09 1985-01-09 Ahi Operations Ltd Intra-vaginal devices
US4327725A (en) 1980-11-25 1982-05-04 Alza Corporation Osmotic device with hydrogel driving member
US4475916A (en) 1982-03-18 1984-10-09 Merck & Co., Inc. Osmotic drug delivery system
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US5366738A (en) 1982-07-29 1994-11-22 Merck & Co., Inc. Controlled release drug dispersion delivery device
US4629449A (en) 1982-07-29 1986-12-16 Alza Corporation Vaginal dispenser for dispensing beneficial hormone
US4578075A (en) 1982-12-20 1986-03-25 Alza Corporation Delivery system housing a plurality of delivery devices
US4681583A (en) 1982-12-20 1987-07-21 Alza Corporation System for dispersing drug in biological environment
US4655219A (en) 1983-07-22 1987-04-07 American Hospital Supply Corporation Multicomponent flexible grasping device
DE3332156A1 (de) 1983-09-06 1985-03-21 Peter 6000 Frankfurt Prezelj Nasenspange
GB8328916D0 (en) 1983-10-28 1983-11-30 Castex Prod Pharmaceutical pellet
GB8403138D0 (en) 1984-02-07 1984-03-14 Graham N B Sustained release of active ingredient
NZ207341A (en) 1984-03-01 1988-02-29 Harvey Alex Ind Ltd Device containing chemical impregnants for insertion into a body cavity of an animal
US4968507A (en) 1984-06-20 1990-11-06 Merck & Co., Inc. Controlled porosity osmotic pump
CH667209A5 (de) 1985-07-02 1988-09-30 Sulzer Ag Medizinische depotsonde.
US5008112A (en) * 1985-12-16 1991-04-16 International Minerals & Chem. Corporation Device for the extended delivery of diffusible agents
US4871542A (en) 1987-04-30 1989-10-03 Ferring Service Center, N.V. Method and apparatus useful for delivering medicinal compositions into the bladder and urinary tract
US5340590A (en) * 1987-06-25 1994-08-23 Alza Corporation Delivery system with bilayer osmotic engine
US4936074A (en) * 1988-11-17 1990-06-26 D. M. Graham Laboratories, Inc. Process for preparing solid encapsulated medicament
US5057318A (en) * 1988-12-13 1991-10-15 Alza Corporation Delivery system for beneficial agent over a broad range of rates
US5545208A (en) 1990-02-28 1996-08-13 Medtronic, Inc. Intralumenal drug eluting prosthesis
US5324280A (en) * 1990-04-02 1994-06-28 Alza Corporation Osmotic dosage system for delivering a formulation comprising liquid carrier and drug
WO1993006792A1 (en) 1991-10-04 1993-04-15 Scimed Life Systems, Inc. Biodegradable drug delivery vascular stent
US5879920A (en) 1991-10-07 1999-03-09 Genencor International, Inc. Coated enzyme-containing granule
PT100944B (pt) 1991-10-10 2000-02-29 Alza Corp Dispositivo para o fornecimento osmotico de farmacos com paredes de materiais hidrofobicos
US5441550A (en) 1992-03-26 1995-08-15 The University Of Tennessee Research Corporation Post-treatment of laminated nonwoven cellulosic fiber webs
US5499997A (en) 1992-04-10 1996-03-19 Sharpe Endosurgical Corporation Endoscopic tenaculum surgical instrument
DE69329407T2 (de) 1992-06-02 2001-05-03 Bard Inc C R Verfahren und Implantatvorrichtung für Langzeitwirkstoffabgabe
US5523092A (en) 1993-04-14 1996-06-04 Emory University Device for local drug delivery and methods for using the same
US5458887A (en) * 1994-03-02 1995-10-17 Andrx Pharmaceuticals, Inc. Controlled release tablet formulation
US5516522A (en) 1994-03-14 1996-05-14 Board Of Supervisors Of Louisiana State University Biodegradable porous device for long-term drug delivery with constant rate release and method of making the same
IL116433A (en) 1994-12-19 2002-02-10 Galen Chemicals Ltd INTRAVAGINAL DRUG DELIVERY DEVICES FOR THE ADMINISTRATION OF 17β-OESTRADIOL PRECURSORS
US5817335A (en) * 1995-05-26 1998-10-06 Alza Corporation Osmotic device with high drug loading and delayed activation of drug delivery
GB9522403D0 (en) 1995-11-01 1996-01-03 Hoechst Roussel Ltd Intravaginal drug delivery device
CN100493647C (zh) 1996-02-02 2009-06-03 精达制药公司 利用可植入系统持续释放活性物质
US6156331A (en) * 1996-02-02 2000-12-05 Alza Corporation Sustained delivery of an active agent using an implantable system
US6171298B1 (en) 1996-05-03 2001-01-09 Situs Corporation Intravesical infuser
GB9610862D0 (en) 1996-05-23 1996-07-31 Evans Brian K Pharmaceutical products
US20070161967A1 (en) * 1996-06-04 2007-07-12 Vance Products Inc., Dba Cook Urological Inc. Implantable medical device with pharmacologically active ingredient
US5869081A (en) 1996-06-28 1999-02-09 The Population Council Progesterone vaginal ring for treatment of infertility
US5797898A (en) 1996-07-02 1998-08-25 Massachusetts Institute Of Technology Microchip drug delivery devices
US5972372A (en) 1996-07-31 1999-10-26 The Population Council, Inc. Intravaginal rings with insertable drug-containing core
US5868719A (en) 1997-01-15 1999-02-09 Boston Scientific Corporation Drug delivery balloon catheter device
US5830230A (en) 1997-03-07 1998-11-03 Micro Therapeutics, Inc. Method of intracranial vascular embolotherapy using self anchoring coils
CA2285591A1 (en) 1997-04-03 1998-10-08 Point Biomedical Corporation Intravesical drug delivery system
IL123813A0 (en) 1997-04-11 1998-10-30 Akzo Nobel Nv Drug delivery system for two or more active substances
EP0981327B1 (en) 1997-05-07 2002-11-06 Galen (Chemicals) Limited Intravaginal drug delivery devices for the administration of testosterone and testosterone precursors
WO1998053758A1 (en) 1997-05-28 1998-12-03 Dec International Nz Limited Intra-vaginal device for pigs
US6197327B1 (en) 1997-06-11 2001-03-06 Umd, Inc. Device and method for treatment of dysmenorrhea
US6039968A (en) 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US5820230A (en) 1997-06-27 1998-10-13 Freeman; Ernie Yieldable debris cutter
DE69724942D1 (de) 1997-07-04 2003-10-23 Thomson Tubes & Displays Farbbildröhre mit einer in-line Elektronenkanone
US6267761B1 (en) 1997-09-09 2001-07-31 Sherwood Services Ag Apparatus and method for sealing and cutting tissue
WO1999018884A1 (en) 1997-10-10 1999-04-22 Duirs Nz Limited Drug delivery system
US6749617B1 (en) 1997-11-04 2004-06-15 Scimed Life Systems, Inc. Catheter and implants for the delivery of therapeutic agents to tissues
US20060141036A1 (en) * 1997-12-12 2006-06-29 Andrx Labs Llc HMG-CoA reductase inhibitor extended release formulation
PT1051217E (pt) * 1997-12-31 2003-12-31 Alza Corp Sistema de controlo osmotico de administracao de medicamento
US6183461B1 (en) 1998-03-11 2001-02-06 Situs Corporation Method for delivering a medication
US6482837B1 (en) 1998-04-24 2002-11-19 University Of Rochester Antimuscarinic compounds and methods for treatment of bladder diseases
JP2002517431A (ja) * 1998-06-11 2002-06-18 イーエム インダストリーズ インコーポレイテッド マイクロ浸透圧制御薬物送達システム
US6464999B1 (en) 1998-06-17 2002-10-15 Galt Incorporated Bioadhesive medical devices
US6159143A (en) 1998-06-17 2000-12-12 Scimed Life Systems, Inc. Method and device for delivery of therapeutic agents in conjunction with isotope seed placement
US6168801B1 (en) 1998-09-09 2001-01-02 Cardiac Pacemakers, Inc. Controlled release drug delivery
WO2000040234A1 (en) 1999-01-06 2000-07-13 Richard Henry Topical anesthesia of the urinary bladder
US6293923B1 (en) 1999-03-15 2001-09-25 Innoventions, Inc. Intravesicular balloon
US6083933A (en) 1999-04-19 2000-07-04 Stellar International Inc. Treatment of cystitis-like symptoms with chondroitin sulfate following administration of a challenge solution
US6139535A (en) 1999-05-27 2000-10-31 Situs Corporation Method and apparatus for placement and activation of a medical device within a body cavity
EP2308522A3 (en) 1999-11-17 2012-02-29 Boston Scientific Limited Microfabricated devices for the delivery of molecules into a carrier fluid
US6808522B2 (en) 1999-12-10 2004-10-26 Massachusetts Institute Of Technology Microchip devices for delivery of molecules and methods of fabrication thereof
US20050238733A1 (en) 2000-01-05 2005-10-27 Richard Henry Topical anesthesia of the urinary bladder
US6753011B2 (en) 2000-01-14 2004-06-22 Osmotica Corp Combined diffusion/osmotic pumping drug delivery system
AU3653301A (en) * 2000-01-28 2001-08-07 Merck & Co., Inc. Treatment or prevention of prostate cancer with a cox-2 selective inhibiting drug
US6379382B1 (en) 2000-03-13 2002-04-30 Jun Yang Stent having cover with drug delivery capability
US6682473B1 (en) 2000-04-14 2004-01-27 Solace Therapeutics, Inc. Devices and methods for attenuation of pressure waves in the body
US7470228B2 (en) 2000-04-14 2008-12-30 Attenuex Technologies, Inc. Method of treating benign hypertrophy of the prostate
US6375972B1 (en) 2000-04-26 2002-04-23 Control Delivery Systems, Inc. Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof
US7232421B1 (en) 2000-05-12 2007-06-19 C. R. Bard, Inc. Agent delivery systems
AU2001265128A1 (en) 2000-05-30 2001-12-11 Massachusetts Institute Of Technology Methods and devices for sealing microchip reservoir devices
US6398718B1 (en) 2000-06-15 2002-06-04 Innoventions, Inc. Intravesicular device
GB0015617D0 (en) 2000-06-26 2000-08-16 Vectura Ltd Improved preparations for dermal delivery of active substances
US20020045668A1 (en) 2000-07-17 2002-04-18 Wenbin Dang Compositions for sustained release of analgesic agents, and methods of making and using the same
WO2002015832A1 (en) 2000-08-24 2002-02-28 Cornell Research Foundation, Inc. Non-hormonal vaginal contraceptive
US6752829B2 (en) 2001-01-30 2004-06-22 Scimed Life Systems, Inc. Stent with channel(s) for containing and delivering a biologically active material and method for manufacturing the same
DE10104369A1 (de) 2001-02-01 2002-08-08 Boehringer Ingelheim Pharma Verwendung von 2-Amino-(4-hydroxy-2-methansulfonamidophenyl)ethanol zur Behandlung der Harninkontinenz
IL157771A0 (en) 2001-03-27 2004-03-28 Galen Chemicals Ltd Intravaginal drug delivery devices for the administration of an antimicrobial agent
US6632217B2 (en) 2001-04-19 2003-10-14 Microsolutions, Inc. Implantable osmotic pump
US6973718B2 (en) 2001-05-30 2005-12-13 Microchips, Inc. Methods for conformal coating and sealing microchip reservoir devices
WO2002099457A1 (en) 2001-05-31 2002-12-12 Massachusetts Inst Technology Microchip devices with improved reservoir opening
US7438701B2 (en) 2001-07-26 2008-10-21 Durect Corporation Local concentration management system
WO2003028660A2 (en) 2001-10-04 2003-04-10 Case Western Reserve University Drug delivery devices and methods
US7722894B2 (en) 2001-10-22 2010-05-25 Massachusetts Institute Of Technology Biodegradable polymer
US7005138B2 (en) 2001-12-21 2006-02-28 Duramed Pharmaceuticals, Inc. Method of systematically delivering SSRIs
US7473273B2 (en) 2002-01-22 2009-01-06 Medtronic Vascular, Inc. Stent assembly with therapeutic agent exterior banding
US8685427B2 (en) 2002-07-31 2014-04-01 Boston Scientific Scimed, Inc. Controlled drug delivery
GB2385273B (en) 2002-02-13 2004-05-26 Deborah Huang Drug delivery device
US6899890B2 (en) 2002-03-20 2005-05-31 Kv Pharmaceutical Company Bioadhesive drug delivery system
US8216609B2 (en) 2002-08-05 2012-07-10 Torrent Pharmaceuticals Limited Modified release composition of highly soluble drugs
DE10247689A1 (de) 2002-10-12 2004-04-22 Martin Rahe Implantat in der Harnblase
US7504387B2 (en) 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
JP2006506385A (ja) 2002-10-22 2006-02-23 ザ バイオメリックス コーポレーション 治療剤を小嚢内デリバリーするための方法およびシステム
US7014636B2 (en) 2002-11-21 2006-03-21 Alza Corporation Osmotic delivery device having a two-way valve and a dynamically self-adjusting flow channel
US9440302B2 (en) 2002-12-16 2016-09-13 The Regents Of The University Of Michigan Assembly and planar structure for use therein which is expandable into a 3-D structure such as a stent and device for making the planar structure
DE60324194D1 (de) 2002-12-23 2008-11-27 Medtronic Inc Katheter mit mehreren infusionsabschnitten und zugehörige methoden
MXPA05010605A (es) 2003-03-31 2005-11-23 Alza Corp Bomba osmotica con medios para disipar la presion interna.
US7598287B2 (en) * 2003-04-01 2009-10-06 Medical College Of Georgia Research Institute, Inc. Use of inhibitors of indoleamine-2,3-dioxygenase in combination with other therapeutic modalities
US20050186289A1 (en) * 2003-04-01 2005-08-25 Medical College Of Georgia Research Institute, Inc. Regulation of T cell-mediated immunity by D isomers of inhibitors of indoleamine-2,3-dioxygenase
DE10323278A1 (de) * 2003-05-21 2004-12-16 Stada Arzneimittel Ag Gebrauchsfertige Gemcitabin-Lösungskonzentrate
US20040249364A1 (en) 2003-06-03 2004-12-09 Ilya Kaploun Device and method for dispensing medication to tissue lining a body cavity
CA2535346A1 (en) 2003-08-13 2005-03-03 Medtronic, Inc. Active agent delivery systems, including a single layer of a miscible polymer blend, medical devices, and methods
US20050228482A1 (en) 2003-09-26 2005-10-13 William Herzog Stent covered by a layer having a layer opening
AU2004277980A1 (en) 2003-09-30 2005-04-14 Alza Corporation Osmotically driven active agent delivery device providing an ascending release profile
DE10359828A1 (de) 2003-12-12 2005-07-28 Zoser B. Dr.Rer.Nat. Salama CHP-Gemcitabin- Kombinationsmittel und ihre Verwendung als Antitumorwirkstoffe, insbesondere Antimetastasierungswirkstoffe
EP1708722B1 (en) 2004-01-28 2014-05-21 The Regents of The University of California Novel interstitial therapy for immediate symptom relief and chronic therapy in interstitial cystitis
JP4680939B2 (ja) 2004-02-10 2011-05-11 シネコー・エルエルシー 治療薬用脈管内送達システム
US7647112B2 (en) 2004-02-11 2010-01-12 Ethicon, Inc. System and method for selectively stimulating different body parts
US20080102119A1 (en) * 2006-11-01 2008-05-01 Medtronic, Inc. Osmotic pump apparatus and associated methods
WO2005115245A1 (en) 2004-05-28 2005-12-08 Dynaventions Inc. Intravesicular device
BRPI0512660A (pt) 2004-06-28 2008-04-01 Lifecycle Pharma As tablete carregável, e, método para a preparação de um tablete
US8361490B2 (en) 2004-09-16 2013-01-29 Theracoat Ltd. Biocompatible drug delivery apparatus and methods
US20060264897A1 (en) 2005-01-24 2006-11-23 Neurosystec Corporation Apparatus and method for delivering therapeutic and/or other agents to the inner ear and to other tissues
EP1871310B1 (en) 2005-04-20 2016-07-27 Cook Medical Technologies LLC Medical apparatus for rapid insertion
US7862552B2 (en) 2005-05-09 2011-01-04 Boston Scientific Scimed, Inc. Medical devices for treating urological and uterine conditions
SI1896006T1 (sl) * 2005-06-08 2010-02-26 Orion Corp Postopek za izdelavo granul, ki vsebujejo entakapon, za oralne odmerne oblike
JP5265359B2 (ja) 2005-08-11 2013-08-14 マサチューセッツ インスティテュート オブ テクノロジー 膀胱内薬物送達デバイスおよび方法
PT1933833E (pt) 2005-09-02 2011-07-08 Theravida Inc Terapia para o tratamento da bexiga superactiva
PL116330U1 (en) * 2005-10-31 2007-04-02 Alza Corp Method for the reduction of alcohol provoked rapid increase in the released dose of the orally administered opioide with prolonged liberation
CA2634160C (en) 2006-01-05 2014-04-15 Lifecycle Pharma A/S Disintegrating loadable tablets
US20070172508A1 (en) 2006-01-26 2007-07-26 Paul Zupkas Transluminal drug delivery methods and devices
US20070172507A1 (en) 2006-01-26 2007-07-26 Paul Zupkas Transluminal drug delivery methods and devices
WO2007109247A2 (en) 2006-03-20 2007-09-27 Duramed Pharmaceuticals, Inc. Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same
SG170806A1 (en) 2006-03-31 2011-05-30 Qlt Plug Delivery Inc Nasolacrimal drainage system implants for drug therapy
US7824383B2 (en) 2006-06-16 2010-11-02 Family Health International Vaginal drug delivery system and method
US20100076261A1 (en) 2006-09-28 2010-03-25 Medvision Inc. Examination device
EP2089010A1 (en) 2006-10-24 2009-08-19 The John Hopkins University Rapid release mini-tablets provide analgesia in laboratory animals
EP2136855A2 (en) 2007-03-20 2009-12-30 Boston Scientific Scimed, Inc. Urological medical devices for release of prostatically beneficial therapeutic agents
EP3470055A1 (en) 2007-06-26 2019-04-17 Allergan Pharmaceuticals International Limited Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
WO2009029958A2 (en) 2007-08-30 2009-03-05 Sunstorm Research Corporation Implantable delivery device
US8470360B2 (en) * 2008-04-18 2013-06-25 Warsaw Orthopedic, Inc. Drug depots having different release profiles for reducing, preventing or treating pain and inflammation
CN201179205Y (zh) * 2007-11-28 2009-01-14 北京星昊医药股份有限公司 双氯芬酸钠双释胶囊片
ES2481454T3 (es) 2007-12-11 2014-07-30 Massachusetts Institute Of Technology Dispositivo implantable de administración de fármacos
US20090317465A1 (en) 2008-06-16 2009-12-24 Appian Labs, Llc Composition and method of preparation of release systems for constant (zero-order) release of active agents
CN102176931B (zh) 2008-08-09 2015-03-04 麻省理工学院 治疗男性泌尿生殖组织和外周组织的可植入药物递送设备和方法
JP5382683B2 (ja) 2008-10-07 2014-01-08 レドックス・バイオサイエンス株式会社 胎児の慢性肺疾患の予防ないし治療剤
ES2838012T3 (es) * 2009-03-12 2021-07-01 Delpor Inc Dispositivo implantable durante un período largo de tiempo de fármacos
US20100247646A1 (en) * 2009-03-26 2010-09-30 Ranbaxy Laboratories Limited Extended release tablets of nisoldipine
US8324180B2 (en) * 2009-04-06 2012-12-04 Eisai Inc. Compositions and methods for treating cancer
US8603521B2 (en) 2009-04-17 2013-12-10 Pharmacyclics, Inc. Formulations of histone deacetylase inhibitor and uses thereof
CA2765630C (en) 2009-06-26 2016-07-05 Taris Biomedical, Inc. Solid drug tablets for implantable drug delivery devices
US9017312B2 (en) * 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8167836B2 (en) * 2009-12-08 2012-05-01 Taris Biomedical, Inc. Tissue expander configured for drug delivery
DK2512581T3 (da) 2009-12-17 2021-03-29 Taris Biomedical Llc Implanterbar indretning med intravesikal tolerance
US20110218488A1 (en) 2010-03-05 2011-09-08 Taris Biomedical, Inc. Systems and Methods for Implanting Devices in the Bladder and Other Genitourinary Sites
JP2012017308A (ja) * 2010-07-09 2012-01-26 Nipro Corp ゲムシタビン水溶液製剤
WO2012048104A1 (en) * 2010-10-06 2012-04-12 Taris Biomedical, Inc. Implantable drug delivery device with bladden retention feature
WO2012048114A1 (en) * 2010-10-06 2012-04-12 Taris Biomedical, Inc. Time-selective bioresorbable or collapsible drug delivery systems and methods
AU2011329638C1 (en) * 2010-11-18 2017-04-27 The General Hospital Corporation Novel compositions and uses of anti-hypertension agents for cancer therapy
JP2014503554A (ja) 2011-01-10 2014-02-13 タリス バイオメディカル，インコーポレイテッド 膀胱痛及び刺激性排尿の持続的治療の使用のためのリドカインレジメン
RU2598057C2 (ru) * 2011-02-04 2016-09-20 ТАРИС Биомедикал ЛЛК Имплантируемое устройство для контролируемого высвобождения лекарственного средства с низкой растворимостью
TWI615155B (zh) 2011-11-01 2018-02-21 拜耳股份有限公司 滲透活性的陰道遞送系統
JP5979931B2 (ja) 2012-03-22 2016-08-31 小林製薬株式会社 医薬組成物
CN104812395A (zh) 2012-08-31 2015-07-29 塔里斯生物医药公司 用于治疗前列腺的药物递送系统和方法
PE20151070A1 (es) 2012-11-02 2015-08-01 Pfizer Inhibidores de la tirosina - quinasa de bruton
JP2016508842A (ja) 2013-03-05 2016-03-24 タリス バイオメディカル エルエルシー 装置の開口部を通じて制御された薬物放出のための薬物送達装置及び方法
AU2014227914B2 (en) 2013-03-15 2018-05-10 Taris Biomedical Llc Drug delivery devices and methods for drug delivery
NZ711546A (en) * 2013-03-15 2017-12-22 Taris Biomedical Llc Drug delivery devices with drug-permeable component and methods
JP6901858B2 (ja) 2014-03-06 2021-07-14 タリス バイオメディカル エルエルシー 薬物送達システム及びゲムシタビンによる膀胱がんの治療方法

Also Published As

Publication number Publication date
WO2015026813A1 (en) 2015-02-26
ZA201600788B (en) 2024-10-30
KR102488491B1 (ko) 2023-01-12
AU2024204252A1 (en) 2024-07-11
US20200360574A1 (en) 2020-11-19
HRP20201421T1 (hr) 2020-12-11
KR102385603B1 (ko) 2022-04-11
MX386955B (es) 2025-03-19
CA2919215C (en) 2022-11-29
JP6486359B2 (ja) 2019-03-20
ZA202205265B (en) 2024-09-25
SMT202000472T1 (it) 2020-11-10
JP2022177236A (ja) 2022-11-30
EP4234036A3 (en) 2023-11-01
IL299897B2 (en) 2024-02-01
SI3035991T1 (sl) 2021-01-29
US20200353131A1 (en) 2020-11-12
ES2817838T3 (es) 2021-04-08
MX2016001621A (es) 2016-06-02
IL282042B1 (en) 2023-03-01
AU2014309012A1 (en) 2016-02-11
RU2016108968A3 (es) 2018-08-28
US10729823B2 (en) 2020-08-04
IL299897B1 (en) 2023-10-01
JP6743213B2 (ja) 2020-08-19
DK3035991T3 (da) 2020-09-21
CA2919215A1 (en) 2015-02-26
IL282042B2 (en) 2023-07-01
EP3736015C0 (en) 2023-06-28
LT3035991T (lt) 2020-11-10
RU2016108968A (ru) 2017-09-26
SG11201600856RA (en) 2016-03-30
KR20220049049A (ko) 2022-04-20
JP2020182875A (ja) 2020-11-12
RU2019112821A (ru) 2019-06-06
IL299897A (en) 2023-03-01
US12447241B2 (en) 2025-10-21
ES2956840T3 (es) 2023-12-29
IL243714A0 (en) 2016-04-21
AU2024204252B2 (en) 2025-12-18
AU2019203394A1 (en) 2019-06-06
PL3035991T3 (pl) 2021-01-25
HUE051336T2 (hu) 2021-03-01
EP3736015B1 (en) 2023-06-28
JP2025157525A (ja) 2025-10-15
JP2016532505A (ja) 2016-10-20
JP2019103837A (ja) 2019-06-27
KR20220049048A (ko) 2022-04-20
AU2019203394B2 (en) 2021-09-09
EP3035991B1 (en) 2020-07-08
US20160199544A1 (en) 2016-07-14
CA3173027A1 (en) 2015-02-26
EP4234036A2 (en) 2023-08-30
RU2687596C2 (ru) 2019-05-15
IL243714B (en) 2021-04-29
AU2021282405A1 (en) 2021-12-23
KR20160045777A (ko) 2016-04-27
RS60847B1 (sr) 2020-10-30
PT3035991T (pt) 2020-10-06
BR112016002646A2 (pt) 2017-08-01
CN113413393A (zh) 2021-09-21
IL282042A (en) 2021-05-31
EP3035991A1 (en) 2016-06-29
CN105530987B (zh) 2021-07-06
AU2014309012B2 (en) 2019-03-14
CN113413393B (zh) 2025-03-04
SG10202004675QA (en) 2020-06-29
KR102503010B1 (ko) 2023-02-24
CN113413537A (zh) 2021-09-21
US20260021224A1 (en) 2026-01-22
CN105530987A (zh) 2016-04-27
JP7674820B2 (ja) 2025-05-12
NZ716207A (en) 2020-12-18
BR112016002646B1 (pt) 2022-01-25
CY1123474T1 (el) 2022-03-24
EP3736015A1 (en) 2020-11-11

Similar Documents

Publication Publication Date Title
ZA202205265B (en) Multi-unit drug delivery devices and methods
EP4628042A3 (en) ROBOTIC SURGICAL DEVICES AND SYSTEMS
EP3013416A4 (en) Systems and methods of delivering therapy using an ambulatory medical device
EP3064240A4 (en) Needle-equipped sysringe, pre-filled syringe, and medical liquid administration device using same
EP2991711A4 (en) DRUGS CHARGE DEVICE
MX2021007933A (es) Dispositivos de suministro de farmacos con un componente permeable al farmaco y metodos.
BR112016024631A2 (pt) cápsulas antimicrobianas para conectores médicos
GB2525005B (en) Delivery system for implantable medical device
EP3090692A4 (en) Implant conveying device and implanted medical instrument
MX2020002693A (es) Formulaciones farmaceuticas estabilizadas de analogos de insulina y/o derivados de insulina.
MX2016005395A (es) Formulacion estable de insulina glulisina.
EP3275482A4 (en) Syringe holder and medical solution administration set
EP3838328A3 (en) Drug delivery devices
IL243786A0 (en) A drug that contains a pharmaceutical combination of dolutegravir, emtricitabine and tenofovir
PH12015502282A1 (en) Alpha-2 adrenoceptor and sigma receptor ligand combinations
MX2016000103A (es) Dispositivo de administracion de farmaco oral y metodos de uso del mismo.
BR112013010339A2 (pt) módulo medicamentoso, sistema de administração de fármaco e dispositivo de administração de fármaco
GB201705375D0 (en) Medicament delivery device adapted to a syringe, a system comprising the medicament delivery device and methods for using said device or system
SG11201702061QA (en) Syringe infusion devices and systems for delivery of active agents
GB201308555D0 (en) Device for safe respiratory administration of volatile medicinal substances
UA60735U (ru) Способ оценки адекватности дозы нейропротектора
AU2014903720A0 (en) Syringe Infusion Devices and Systems for Delivery of Active Agents
AU2014903710A0 (en) Syringe infusion devices and systems for delivery of active agents
GB201311256D0 (en) Medical and dental needle safety device
UA25230S (uk) Медичний пристрій для введення лікувальних препаратів